Christopher Murray
Chief Tech/Sci/R&D Officer at BLUEPRINT MEDICINES CORPORATION
Net worth: 3 M $ as of 2024-03-30
Profile
Christopher K.
Murray is currently the Chief Technical Operations & Quality Officer at Blueprint Medicines Corp.
Prior to this, he worked at ARIAD Pharmaceuticals, Inc. for 13 years, where he held the position of Vice President-Technical Operations from 2013 to 2017.
Murray received his undergraduate degree from Hope College in 1984 and his graduate degree from The University of Chicago in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-06 | 33,853 ( 0.06% ) | 3 M $ | 2024-03-30 |
Christopher Murray active positions
| Companies | Position | Start |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 2017-10-09 |
Former positions of Christopher Murray
| Companies | Position | End |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-04-30 |
Training of Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher Murray
